Showing results (351-360 of 744) with videos related to

Sort By:
Pageof 75
Nature Reviews. Clinical Oncology|December 2, 2024
Getting the right combination to break the epigenetic codeSeda S Tolu, Aaron D Viny, Jennifer E Amengual, et al.
The Oncologist|October 22, 2025
Cancer Interception During Treatment: Using Growth Kinetics to Create a Continuous Variable for Assessing Disease ResponseMengxi Zhou, Antonion T Fojo, Lawrence H Schwartz, et al.
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Clinical Toxicities of Histone Deacetylase InhibitorsSrividya Subramanian, Susan E Bates, John J Wright, et al.
Molecular Cancer Research : MCR|February 1, 2008
Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cellsKenneth K W To, Orsolya Polgar, Lyn M Huff, et al.
Journal of the National Cancer Institute|February 25, 2021
Patient-Reported Outcomes and Long-Term Nonadherence to Aromatase InhibitorsDawn L Hershman, Alfred I Neugut, Anna Moseley, et al.
Environmental Research|August 25, 2004
Environmental tobacco smoke and breast cancer incidenceMarilie D Gammon, Sybil M Eng, Susan L Teitelbaum, et al.
Breast Cancer Research and Treatment|June 6, 2006
IGHMBP2 Thr671Ala polymorphism might be a modifier for the effects of cigarette smoking and PAH-DNA adducts to breast cancer riskJing Shen, Mary Beth Terry, Marilie D Gammon, et al.
Breast Cancer Research and Treatment|July 13, 2007
Genetic variation of TP53, polycyclic aromatic hydrocarbon-related exposures, and breast cancer risk among women on Long Island, New YorkMia M Gaudet, Marilie D Gammon, Jeannette T Bensen, et al.
Pageof 75